Meeting us at Pharma CI USA 2026, Newark · Sept 16–17? Reserve a booth meeting →
Decision-grade AI for BioPharma.
Anervea builds the intelligence layer pharma teams run on - competitive intelligence, commercial analytics, and clinical development - on one data infrastructure, with 110+ global sources read by AI and validated by human experts.
Live in production at global pharma
Deploys in weeks
ISO 27001 · GDPR · HIPAA
110+ global sources
unified on one data spine
AI + expert validation
machines read, humans verify
Enterprise-grade security
built for pharma's toughest reviewers
Deploys in weeks
not quarters
- The cost of slow intelligence
BioPharma runs on decisions.
The old tools can't keep up with them.
6-8
wks
Static landscape decks
Consultant readouts are thorough - and outdated on arrival. Two competitors post data and one changes strategy before the deck reaches leadership.
TIME COST - HISTORY, NOT INTELLIGENCE
10+
Fragmented tools & dashboards
Registries, databases, alert feeds, BI tools - every team reads a different picture of the same market, and reconciling them becomes a full-time job.
TIME COST - ONE MARKET, TEN VERSIONS OF IT
40+
hrs
Manual monitoring, every month
Analysts spend their hours reading and reformatting instead of thinking. The critical signal looks exactly like noise - until it's too late to act on it.
TIME COST - READING, NOT DECIDING
- The Anervea platform suite
One data spine. Three decision platforms.
Every Anervea product is built the same way: deep data infrastructure (Nexus), intelligence models on top, and applications designed for the pharma teams that use them.
Competitive Intelligence
alfakinetic™
Real-time competitive intelligence across the drug development and commercialization lifecycle.
Monitoring & alerts from 110+ global sources
Competitor 360°s, trial & endpoint comparisons
Congress intelligence & AI InsightWizard
Predictive analytics incl. approval likelihood
For CI · Commercial · Medical Affairs · BD&L
Commercial Analytics
alfaTRx™
Analytics-as-a-service with AI-powered chat - ask questions in plain language, get instant answers from your commercial data.
Custom dashboards, fully on-brand
Conversational AI over sales & market data
Embedded, real-time - no complex setup
Scales across the whole organization
For Commercial · Brand · Analytics teams
Clinical Development
alfadev™
Trial feasibility, site selection, and enrollment intelligence built on 330M+ real-world US patient journeys.
Defensible site selection in days
Fewer zero-enrolling sites & amendments
Powered by Komodo Health data
Enterprise-ready in 2–4 weeks
For Clinical Operations · Development
Need something bespoke? Enterprise Pharma AI and Advisory Services extend the same data spine to your custom use case - ask in the demo.
- A look inside
The platforms, as your team will see them
Live interface previews - pick a platform.
Every competitor, trial, congress and deal in your therapeutic area - monitored continuously, compared automatically, and summarized for the decision in front of you.
- Competitive intelligence
Your whole landscape, watching itself
Phase-by-phase pipeline landscape, always current
Alerts with recommendations, not just links
One-click export to branded PPT, PDF, Excel
- Try the thinking, right here
Ask Anervea
This is how your team will work: a question in plain language, an answer with sources. Pick one.
- Everything a decision needs
Built like the best AI products.
Grounded in pharma.
Real-time alerts
Signals filtered to your assets - with a recommendation attached, not just a link.
PDUFA date set
-Q2 2027, competing Launch model updated.
Approval forecasts
AI-modeled likelihood of FDA approval for pipeline assets - plan against the future.
Competitor A Ph III
Congress intelligence
Abstracts synthesized while the meeting is still running - not three weeks after.
412
ESMO abstracts
36
flagged for you
Trial & endpoint comparisons
TPPs, survival outcomes, and endpoints side by side - the table your team builds by hand today.
Your asset
Proteinuria @ 36 wk · Q3 '27
Competitor A
eGFR slope @ 104 wk · Q1 '28
One-click reporting
Branded, board-ready deliverables the moment leadership asks.
PPT
Excel
Auto-Updated
Built-in collaboration
Comments, shared workspaces, uploads with AI summaries - CI the whole org can use.
MA
Flagging for launch team - this moves our window by ~2 quarters
Why Teams Trust Anervea
AI speed. Human judgment. Pharma-grade both ways.
Nexus - one data infrastructure
Every platform draws from the same deep data spine: 110+ global sources, registries, regulators, publications, deal flow - continuously refreshed.
Validated by human experts
Anervea is part of the GROWMAN Group alongside GRG Health - the proprietary expert network powering our primary intelligence layer across four countries.
Enterprise-grade security
ISO 27001 certified, GDPR and HIPAA-aligned, built on AWS - with a modular architecture that deploys in weeks, not quarters.
110+
Global data sources unified in Nexus
330M+
Real-world patient journeys (alfadev™)
50%
Research hours reclaimed by client teams
24/7
Continuous market coverage
Why Teams Trust Anervea
Teams that switched aren't going back
alfakinetic™ reduced our research hours by half - giving real-time visibility into competitor pipelines and regulatory changes.
COMPETITIVE INTELLIGENCE LEAD · GLOBAL PHARMA
For the first time, we can see everything in one place - news alerts, trial updates, competitor 360s, full landscapes. It's streamlined our workflows and democratized CI across the org.
INSIGHTS & ANALYTICS DIRECTOR · BIOPHARMA
Resource Library
Take something useful, even before the demo
The fastest way to evaluate
See Anervea on your own therapeutic area
Pick your TA and the platform that fits your team - we configure before the call
Walk a live workspace: alerts, landscapes, analytics, or feasibility - no slideware
Leave with a clear view of fit, deployment timeline, and pricing
30 minutes
- live in the platform, not a deck
Your indication
- workspace configured in advance
Direct answers
- including pricing, in the first call
No obligation
- if it's not a fit, you'll know in 30 minutes
Common Questions
Asked by every serious buyer
Legacy platforms are archives - deep, structured, excellent at storing what happened. Anervea builds decision layers: platforms that monitor continuously, connect signals across sources, and deliver the conclusion your team would otherwise spend days assembling. Many clients run Anervea alongside an existing database; the difference is who does the synthesis.
Yes. Anervea is part of the GROWMAN Group alongside GRG Health, the proprietary expert network powering our primary intelligence layer across four countries. AI surfaces the signals; domain experts verify the ones that matter before they reach your desk.
alfakinetic™ for competitive intelligence across CI, commercial, medical affairs and BD&L; alfaTRx™ for commercial analytics teams; alfadev™ for clinical operations and development. They share one data spine, so many clients start with one platform and expand. The demo starts with your use case, not our catalogue.
Weeks, not quarters. Platforms are configured to your therapeutic areas, assets, workflows and governance requirements - alfadev™, for example, is enterprise-ready in 2–4 weeks. Your team sees live intelligence on their own market during onboarding.
Anervea is ISO 27001 certified, GDPR and HIPAA-aligned, and built on AWS with a modular, microservices architecture. Your configurations, queries, and internal documents remain yours - security specifics are covered openly in the demo.
Anervea for BioPharma
We configure your workspace before we ever get on the call.
Tell us your therapeutic area and where you sit . we'll have the right platform loaded with your market when you join.
You tell us who you are
Company and function, below.
We configure a workspace
Loaded with your competitors and pipeline, in advance.
You walk the live platform
Leave with a clear view of fit, deployment timeline, and pricing
Request a demo
Tell us your therapeutic area and where you sit . we'll have the right platform loaded with your market when you join.
